17 分鐘

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease JAMA Neurology Author Interviews

    • 醫學

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

  • American Medical Association, 2020

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

17 分鐘

  • American Medical Association, 2020

JAMA Network的更多節目

JAMA Clinical Reviews
JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Medical News
JAMA Network
JAMAevidence Users' Guides to the Medical Literature
JAMAevidence Users' Guides to the Medical Literature
JAMA Network
JAMA Psychiatry Author Interviews
JAMA Psychiatry Author Interviews
JAMA Network
JAMA Oncology Author Interviews
JAMA Oncology Author Interviews
JAMA Network
JAMA Author Interviews
JAMA Author Interviews
JAMA Network